The use of misoprostol as a prevention for post-partum hemorrhage after cesarean ection
DOI:
https://doi.org/10.35335/midwifery.v11i1.1242Keywords:
Caesarean Section, Misoprostol, Postpartum HemorrhageAbstract
This systematic literature review was organized to evaluate a potential uterotonic agent named misoprostol, as the choice to prevent and manage PPH. Compiled this systematic review using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guide to analyze the role and efficacy of misoprostol for the prevention of post-partum bleeding after cesarean section. A literature search was conducted on five databases, namely MEDLINE, The Cochrane Library, Wiley Sciencedirect, and Google Scholar based on the PRISMA guide lists. Quality and risk assessments were carried out through the Cochrane Risk of Bias Tool 2.0 checklist and any disagreements among the authors that were resolved by discussion. Literature search and selection resulted in ten studies that met the inclusion and exclusion criteria. Misoprostol has been shown to reduce post-caesarean bleeding compared to other agents. Evaluation then was carried out through decreased hemoglobin, hematocrit, visual evaluation of bleeding, as well as the need for additional blood transfusions and uterotonic agents. The high incidence of PPH in caesarean section and the magnitude of the accompanying risks indicate the importance of a form of PPH prevention to improve the safety of mother and baby. The results obtained from this study showed the safety and effectiveness of misoprostol in the treatment of PPH after caesarean section.
Downloads
References
Akter, S., Hossain Khan, M. S., Khatun, K., Nahar, S., & Akter, S. (2022). Efficacy and Safety of Misoprostol for Prevention of Post-Partum Haemorrhage: A Comparative Study. Journal of National Institute of Neurosciences Bangladesh, 7(2). https://doi.org/10.3329/jninb.v7i2.58111
Bilgin, Z., & Kömürcü, N. (2019). Comparison of the effects and side effects of misoprostol and oxytocin in the postpartum period: A systematic review. Taiwanese Journal of Obstetrics and Gynecology, 58(6), 748–756. https://doi.org/10.1016/j.tjog.2019.09.004
Bláha, J., & Bartošová, T. (2022). Epidemiology and definition of PPH worldwide. Best Practice and Research: Clinical Anaesthesiology, 36(3–4), 325–339. https://doi.org/10.1016/j.bpa.2022.11.001
Butwick, A. J., Ramachandran, B., Hegde, P., Riley, E. T., El-Sayed, Y. Y., & Nelson, L. M. (2017). Risk Factors for Severe Postpartum Hemorrhage after Cesarean Delivery: Case-Control Studies. Anesthesia and Analgesia, 125(2), 523–532. https://doi.org/10.1213/ANE.0000000000001962
Durham, J., Phengsavanh, A., Sychareun, V., Hose, I., Vongxay, V., Xaysomphou, D., & Rickart, K. (2018). Misoprostol for the prevention of postpartum hemorrhage during home births in rural Lao PDR: Establishing a pilot program for community distribution. International Journal of Women’s Health, 10, 215–227. https://doi.org/10.2147/IJWH.S150695
Hobday, K., Zwi, A. B., Homer, C., Kirkham, R., Hulme, J., Wate, P. Z., & Prata, N. (2020). Misoprostol for the prevention of post-partum haemorrhage in Mozambique: An analysis of the interface between human rights, maternal health and development. BMC International Health and Human Rights, 20(1). https://doi.org/10.1186/s12914-020-00229-9
Karim, F., Ali, N. B., Khan, A. N. S., Hassan, A., Hasan, M. M., Hoque, D. M. E., Billah, S. M., Arifeen, S. El, & Chowdhury, M. A. K. (2020). Prevalence and factors associated with caesarean section in four hard-to-reach areas of Bangladesh: Findings from a cross-sectional survey. PLoS ONE, 15(6). https://doi.org/10.1371/journal.pone.0234249
Krugh, M., & Maani, C. V. (2021). Misoprostol - StatPearls - NCBI Bookshelf. StatPearls.
Li, X., Zhang, W., Lin, J., Liu, H., Yang, Z., Teng, Y., Duan, S., Li, Y., Xie, Y., Lin, X., Xie, L., Peng, Q., Huang, J., Chen, J., Duan, W., Luo, J., & Zhang, J. (2018). Preterm birth, low birthweight, and small for gestational age among women with preeclampsia: Does maternal age matter? Pregnancy Hypertension, 13, 260–266. https://doi.org/10.1016/j.preghy.2018.07.004
Liu, C. ning, Yu, F. bing, Xu, Y. zhe, Li, J. sheng, Guan, Z. hong, Sun, M. na, Liu, C. an, He, F., & Chen, D. jin. (2021). Prevalence and risk factors of severe postpartum hemorrhage: a retrospective cohort study. BMC Pregnancy and Childbirth, 21(1). https://doi.org/10.1186/s12884-021-03818-1
Lontaan, A., Sukmawati, E., Widya Larasati, E., Sundary Lintang, S., Wayan Armini, N., Chairiyah, R., & Bayu Argaheni, N. (2023). PIJAT DAN SPA BAYI (Neila Sulung & Ilda Melisa (Eds.); 2023rd ed., Vol. 1). GET Press Indonesia. www.globaleksekutifteknologi.co.id
Mishra, N., Nekkanti, L. P., Barma, P., Mishra, I., & Mishra, I. (2021). Adjunctive misoprostol for prevention of post-partum haemorrhage: a pragmatic strategy of selective sequential administration. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 10(2). https://doi.org/10.18203/2320-1770.ijrcog20210325
Morfaw, F., Fundoh, M., Pisoh, C., Ayaba, B., Mbuagbaw, L., Anderson, L. N., & Thabane, L. (2019). Misoprostol as an adjunct to oxytocin can reduce postpartum-haemorrhage: A propensity score-matched retrospective chart review in Bamenda-Cameroon, 2015-2016. BMC Pregnancy and Childbirth, 19(1). https://doi.org/10.1186/s12884-019-2407-3
Muhammad, R., Isah, A., Agida, T., & Akaba, G. (2019). A prospective study to compare the effectiveness of adjunctive rectal misoprostol or oxytocin titration in the prevention of primary post-partum haemorrhage in at risk patients. African Health Sciences, 19(1). https://doi.org/10.4314/ahs.v19i1.25
Othman, E. R., Fayez, M. F., El Aal, D. E. M. A., El-Dine Mohamed, H. S., Abbas, A. M., & Ali, M. K. (2016). Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial. Taiwanese Journal of Obstetrics and Gynecology, 55(6), 791–795. https://doi.org/10.1016/j.tjog.2016.02.019
Prata, N., & Weidert, K. (2016). Efficacy of misoprostol for the treatment of postpartum hemorrhage: Current knowledge and implications for health care planning. International Journal of Women’s Health, 8, 341–349. https://doi.org/10.2147/IJWH.S89315
Ragab, A., Barakat, R., & Alsammani, M. A. (2016). A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. International Journal of Gynecology and Obstetrics, 132(1), 82–84. https://doi.org/10.1016/j.ijgo.2015.06.057
Rasri, W. (2018). Intrauterine Misoprostol plus Intravenous Oxytocin for Reduction of Blood Loss in Cesarean Delivery. Thai Journal of Obstetrics and Gynaecology, 26(4), 237–245.
Sallam, H. F., & Shady, N. W. (2018). Adjunctive sublingual misoprostol for secondary prevention of post-partum hemorrhage during cesarean delivery: double blind placebo randomized controlled trial. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 7(2). https://doi.org/10.18203/2320-1770.ijrcog20180161
Shrestha, A., Dongol, A., Chawla, C. D., & Adhikari, R. (2011). Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage. Kathmandu University Medical Journal, 9(33). https://doi.org/10.3126/kumj.v9i1.6254
Singangutti, R. (2018). Intramuscular methergine versus per-rectal misoprostol for prevention of atonic post-partum haemorrhage. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 7(4). https://doi.org/10.18203/2320-1770.ijrcog20181341
Sugiyono. (2019). Metode Penelitian Kuantitatif, Kualitatif, dan R&D (1st ed.). Penerbit Alfabeta.
Sukmawati, E. (2018). wahyunita yulia sari, indah sulistyoningrum. Farmakologi Kebidanan. Trans Info Media (TIM).
Sukmawati E, wahyunita yulia sari, & indah sulistyoningrum. (2018). Farmakologi Kebidanan. Trans Info Media (TIM). https://scholar.google.com/scholar?oi=bibs&cluster=11760770443894442881&btnI=1&hl=id
Sweed, M., El-Said, M., Abou-Gamrah, A., & Ali, M. (2019). Comparison between 200, 400 and 600 microgram rectal misoprostol before cesarian section: A randomized clinical trial. Journal of Obstetrics and Gynaecology Research, 45(3). https://doi.org/10.1111/jog.13883
Sweed, M. S., El-Saied, M. M., Abou-Gamrah, A. E., El-Sabaa, H. A., Abdel-Hamid, M. M., Hemeda, H., Mansour, A. M., Shawky, M. E., El-Sayed, M. A., & Mohamed, R. M. (2018). Rectal vs. sublingual misoprostol before cesarean section: double-blind, three-arm, randomized clinical trial. Archives of Gynecology and Obstetrics, 298(6), 1115–1122. https://doi.org/10.1007/s00404-018-4894-2
The Efficacy and Safety of Intrauterine Misoprostol During Cesarean Section in Prevention of Primary Post-Partum Hemorrhage - A Randomized Controlled Trial. (2022). International Journal on Obstetrics and Gynecology, 2(1). https://doi.org/10.51626/ijog.2022.02.00010
World Health Organization. (2022). WHO postpartum haemorrhage (PPH) summit. Project Brief , 1.
